Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Epidemiology

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kws204PMID 22814370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for prediction of cardiovascular events and mortality in a Middle Eastern population

  2012cited by this paper
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the ‘old’ versus the ‘new’ Framingham equation

  2011cited by this paper
• Predictive accuracy of the ‘Framingham’s general CVD algorithm’ in a Middle Eastern population: Tehran Lipid and Glucose Study

  2011cited by this paper
• Performance of current guidelines for coronary heart disease prevention: optimal use of the Framingham-based risk assessment.

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

  2011cited by this paper
• Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures

  2010cited by this paper
• New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population

  2010cited by this paper
• Clinical Prediction Models—a Practical Approach to Development, Validation and Updating

  2009influential reference
• Recalibration of a Framingham risk equation for a rural population in India

  2009cited by this paper
• Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population.

  2009cited by this paper
• Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population

  2009cited by this paper
• Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II

  2009influential reference
• Risk scores for prediction of coronary heart disease: an update.

  2009cited by this paper
• Using relative utility curves to evaluate risk prediction

  2009cited by this paper
• An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

  2009cited by this paper
• Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures

  2009cited by this paper
• Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study.

  2009cited by this paper
• Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering

  2009cited by this paper
• Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile

  2009cited by this paper
• Glucose intolerance and risk of cardiovascular disease in Iranian men and women: Results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS)

  2009cited by this paper
• Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers

  2008cited by this paper
• Bmc Medical Informatics and Decision Making Extensions to Decision Curve Analysis, a Novel Method for Evaluating Diagnostic Tests, Prediction Models and Molecular Markers

  2008cited by this paper
• Aspirin chemoprevention: one size does not fit all.

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008influential reference
• Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

  2007cited by this paper
• Validity of the Framingham point scores in the elderly: results from the Rotterdam study.

  2007cited by this paper
• EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Cardiovascular risk prediction tools for populations in Asia

  2007cited by this paper
• AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions.

  2007cited by this paper
• Prediction of first coronary events with the Framingham score: a systematic review.

  2007cited by this paper
• Explained Variation for Survival Models

  2006cited by this paper
• Decision Curve Analysis: A Novel Method for Evaluating Prediction Models

  2006influential reference
• Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases.

  2005cited by this paper
• Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.

  2004cited by this paper
• Clinical prediction models: are we building better mousetraps?

  2003cited by this paper
• Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures

  2003cited by this paper
• Life course epidemiology

  2003cited by this paper
• An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

  2003cited by this paper
• Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1)

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Decision Making in Health and Medicine: Integrating Evidence and Values

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study

  2001cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

  1994cited by this paper
• An updated coronary risk profile. A statement for health professionals.

  1991cited by this paper
• Silent myocardial ischemia and infarction: insights from the Framingham Study.

  1986cited by this paper
• Intermittent claudication.

  1971cited by this paper
• Intermittent Claudication: Incidence in the Framingham Study

  1970cited by this paper

• External validation of the PREVENT risk score: performance and clinical utility in an Iranian population.

  2026cites this paper
• Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas

  2025cites this paper
• Validation and clinical usefulness of the SCORE2 cardiovascular risk prediction algorithms in an Iranian population

  2025cites this paper
• Performance of the revised WHO cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study.

  2025cites this paper
• Assessing the association between dairy consumption and the 10-year Framingham Risk Score in women

  2025cites this paper
• Quantification of Cardiovascular Disease Risk Among Hypertensive Subjects in Active Romanian Population Using New Echocardiographic, Biological and Atherogenic Markers

  2025influential citation
• Comorbidity and cardiovascular risk factors in multiple sclerosis

  2025cites this paper
• Higher ultra-processed food intake is associated with an increased incidence risk of cardiovascular disease: the Tehran lipid and glucose study

  2024cites this paper
• The association of osteoporosis and cardiovascular disease risk score based on the Framingham and ACC/AHA risk prediction models: a cross-sectional analysis of Bushehr Elderly Health Program

  2023cites this paper
• Dietary sodium to potassium ratio is an independent predictor of cardiovascular events: a longitudinal follow-up study

  2023cites this paper
• Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys

  2023cites this paper
• Validity of the models predicting 10-year risk of cardiovascular diseases in Asia: A systematic review and prediction model meta-analysis

  2023cites this paper
• Dietary oxalate to calcium ratio and incident cardiovascular events: a 10-year follow-up among an Asian population

  2022cites this paper
• Supplemental Online Content

  2021cites this paper
• Evaluation of Cardiovascular Diseases Risk in the Iranian Population

  2021cites this paper
• An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country: Developing and validating an office-based model to predict cardiovascular mortality using cohorts of a middle-income country.

  2021cites this paper
• Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models

  2021cites this paper
• Perbandingan Hasil Framingham Risk Score (FRS) dan QRISK2 Pada Dewasa Usia Produktif terhadap WHO Chart

  2021cites this paper
• Assessment of a Comprehensive Early Childhood Education Program and Cardiovascular Disease Risk in Midlife

  2021cites this paper
• Progress and challenges of network meta‐analysis

  2021cites this paper
• Association of nut and legume consumption with Framingham 10 year risk of general cardiovascular disease in older adult men: A cross-sectional study.

  2021cites this paper
• Short sleep is associated with higher prevalence and increased predicted risk of cardiovascular diseases in an Iranian population: Fasa PERSIAN Cohort Study

  2020cites this paper
• External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population

  2020cites this paper
• Correlation of blood glucose with lipid profile levels as risks for cardiovascular disease among diabetic patients at Ruhengeri referral hospital

  2020cites this paper
• Withdrawn

  2020cites this paper
• Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)

  2020cites this paper
• Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients

  2020cites this paper
• Estimation of the 10-Year Risk of Cardiovascular Diseases: Using the SCORE, WHO/ISH, and Framingham Models in the Shahrekord Cohort Study in Southwestern Iran

  2020cites this paper
• Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran

  2020cites this paper
• Association of dietary fatty acids and the incidence risk of cardiovascular disease in adults: the Tehran Lipid and Glucose Prospective Study

  2020cites this paper
• The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study

  2020influential citation
• External validation of the European risk assessment tool for cardio metabolic disease in a Middle Eastern population

  2020cites this paper
• Tea, coffee, caffeine intake and the risk of cardio-metabolic outcomes: findings from a population with low coffee and high tea consumption

  2019cites this paper
• World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

  2019cites this paper
• Food Patterns and Framingham Risk Score in Iranian Adults: Tehran Lipid and Glucose Study: 2005–2011

  2018cites this paper
• Total antioxidant capacity of the diet modulates the association between habitual nitrate intake and cardiovascular events: A longitudinal follow-up in Tehran Lipid and Glucose Study

  2018cites this paper
• Shift Work and the Risk of Cardiovascular Diseases and Metabolic Syndrome Among Jordanian Employees.

  2018cites this paper
• Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study

  2018cites this paper
• Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study

  2018cites this paper
• Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein

  2018cites this paper
• Lipoprotein-Associated Phospholipase A2 Activity increase the Sensitivity of Framingham Score for detecting the incidence of Acute Myocardial Infarction in sub-population of Indonesian Male Patients

  2017cites this paper
• Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores

  2017cites this paper
• Cardiovascular risk assessment by FRS and SCORE in Iranian adult population

  2017cites this paper
• Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.

  2017cites this paper
• Impact of blood pressure, cholesterol and glucose in the association between adiposity measures and coronary heart disease and stroke among Iranian population.

  2017cites this paper
• Longitudinal Associations of High-Fructose Diet with Cardiovascular Events and Potential Risk Factors: Tehran Lipid and Glucose Study

  2017cites this paper
• PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region

  2017cites this paper
• Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.

  2016cites this paper
• Prediction models for cardiovascular disease risk in the general population: systematic review

  2016cites this paper
• Wrist circumference as a novel negative risk factor for cardiovascular disease among adult men: a median follow-up of 9 years

  2016cites this paper
• Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran.

  2016cites this paper
• Short-term predictive ability of selected cardiovascular risk prediction models in a rural Bangladeshi population: a case-cohort study

  2016cites this paper
• Epidemiological Patterns of Road Traffic Crashes During the Last Two Decades in Iran: A Review of the Literature from 1996 to 2014

  2016cites this paper
• Regression dilution bias in blood pressure and body mass index in a longitudinal population-based cohort study.

  2015cites this paper
• بار درمان استاتین در جمعیت شهری ایران بر اساس راهنمای بالینی جدید ACC/AHA

  2015cites this paper
• Hypertension phenotypes and incident cardiovascular disease and mortality events in a decade follow-up of a Middle East cohort

  2015cites this paper
• A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study.

  2015influential citation
• The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran

  2015cites this paper
• Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study

  2015cites this paper
• A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.

  2015cites this paper
• Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study

  2015cites this paper
• Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk

  2015cites this paper
• The burden of statin therapy in urban population of Iran based on new ACC/AHA guideline

  2015cites this paper
• Fatores de risco cardiovascular do Escore de Framingham entre hipertensos assistidos por equipes de Saúde da Família

  2014cites this paper
• Sensitivity and Specificity Can Change in Opposite Directions When New Predictive Markers Are Added to Risk Models

  2014cites this paper
• Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease.

  2014cites this paper
• The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study

  2014cites this paper
• [Cardiovascular risk factors on the Framingham Risk Score among hypertensive patients attended by family health teams].

  2014cites this paper
• Cognitive Aging : Role of Cardiovascular Disease Risk Factors

  2013cites this paper
• Cardiovascular Disease Risk Assessment: Insights from Framingham.

  2013cites this paper
• Predicting cognitive decline

  2013cites this paper
• The authors reply.

  2013cites this paper
• Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study".

  2013cites this paper
• External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study.

  2013cites this paper
• Spécialité: Santé Publique Option: Epidémiologie

  2013cites this paper
• Multivariable Evaluation of Candidates for Cardiovascular Disease

  2013cites this paper
• Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance.

  2012influential citation
• Framingham Vascular Risk Scores Predicting Cognitive Decline : a Dementia Risk Score Vs The

  year unknowncites this paper